Chemoinformaics analysis of 2-HYDROXY-1-PHENYLETHANONE
| Molecular Weight | 136.15 | nRot | 2 |
| Heavy Atom Molecular Weight | 128.086 | nRig | 26 |
| Exact Molecular Weight | 136.052 | nRing | 1 |
| Solubility: LogS | -6.538 | nHRing | 0 |
| Solubility: LogP | 3.852 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 20.2983 |
| nHD | 1 | BPOL | 8.89366 |
| QED | 0.657 |
| Synth | 2.491 |
| Natural Product Likeliness | 0.786 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.129 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -5.097 |
| MDCK | 0.0000668 |
| BBB | 0.097 |
| PPB | 0.932577 |
| VDSS | 0.978 |
| FU | 0.0131183 |
| CYP1A2-inh | 0.944 |
| CYP1A2-sub | 0.78 |
| CYP2c19-inh | 0.974 |
| CYP2c19-sub | 0.153 |
| CYP2c9-inh | 0.749 |
| CYP2c9-sub | 0.927 |
| CYP2d6-inh | 0.843 |
| CYP2d6-sub | 0.944 |
| CYP3a4-inh | 0.904 |
| CYP3a4-sub | 0.194 |
| CL | 13.266 |
| T12 | 0.189 |
| hERG | 0.148 |
| Ames | 0.853 |
| ROA | 0.043 |
| SkinSen | 0.292 |
| Carcinogencity | 0.921 |
| EI | 0.154 |
| Respiratory | 0.637 |
| NR-Aromatase | 0.414 |
| Antiviral | No |
| Prediction | 0.891946 |